2026-525360-18-00RecruitingPhase 1
A First-in-Human Study of INCA035784 in Participants With Myeloproliferative Neoplasms
Conditions
Trial Snapshot
- Phase
- Phase 1
- Status
- Recruiting
- Sponsor
- Incyte Corp.
- Enrollment
- 40
- Locations
- 10
Study Overview
Brief Summary
No summary available.
Eligibility Criteria
- Ages
- 18 years to 65+ years (18-64 Years, 65+ Years)
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- Not provided
Exclusion Criteria
- Not provided
Investigators
Clinical Trial Information
Scientific
Incyte Corp.
Study Sites (10)
Loading locations...
Similar Trials
Recruiting
Phase 1
A Phase 1, Open-Label, Multicenter Study of INCA033890 in Participants with Advanced or Metastatic Solid Tumors2022-502456-31-00Incyte Corp.75
Recruiting
Phase 1
A Phase 1, Open-Label, Multicenter Study of INCA036873 in Participants With Advanced Solid Tumors and Hematological MalignanciesHematological malignanciesAdvanced solid tumors2025-523130-11-00Incyte Corp.150
Recruiting
Phase 1
A Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of INCA033989 Following Subcutaneous or Intravenous Administration in Healthy Adult ParticipantsNCT07448155Incyte Corporation126
Recruiting
Phase 1
Study of INCA036978 in Participants With Myeloproliferative NeoplasmsNCT07441694Incyte Corporation218
Recruiting
Phase 1
First-in-Human Study of RO78126532025-522101-37-00F. Hoffmann-La Roche AG12